What value per share was used for the CHE stock award to the director?

The award is reported at $440.77 per share. This figure represents the grant-date price per share used for reporting the value of the 386-share capital stock award, rather than a price from an open-market transaction.

Chemed (NYSE: CHE) director granted 386 capital shares in stock award

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

CHEMED CORP director John Meredith Mount Jr. reported a compensation-related stock award of capital stock. He received 386 shares on May 18, 2026, described as an award of stock in the footnotes. The grant was valued at $440.77 per share for reporting purposes. After this award, his direct holdings increased to 1,316 shares of Chemed capital stock. This is a non-derivative, grant/award acquisition rather than an open-market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Mount John Meredith Jr.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Capital Stock	386	$440.77	$170K

Holdings After Transaction: Capital Stock — 1,316 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Stock award size: 386 shares Grant price per share: $440.77 per share Holdings after award: 1,316 shares

3 metrics

Stock award size 386 shares Non-derivative grant of Chemed capital stock on May 18, 2026

Grant price per share $440.77 per share Reported value for the 386-share stock award

Holdings after award 1,316 shares Director’s direct Chemed capital stock holdings following the transaction

Key Terms

Grant, award, or other acquisition, Capital Stock, Award of stock

3 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Capital Stock financial

"security_title: Capital Stock"

Capital stock is the total set of shares that represent ownership in a company, including different classes such as common and preferred stock. Think of it as the number and types of slices in a company’s ownership pie: it matters to investors because it determines voting power, entitlement to dividends, and how a company’s value is divided per share, so changes in capital stock can dilute holdings or alter per‑share metrics.

Award of stock financial

"footnote: Award of stock"

Form 4 Insider Transactions: What Each Field Means →

05/19/2026 - 09:56 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mount John Meredith Jr.

(Last)

(First)

(Middle)

2906 MABRY ROAD NE

(Street)

ATLANTA

GEORGIA

30319

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CHEMED CORP [ CHE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Capital Stock	05/18/2026		A		386	A⁽¹⁾	$440.77	1,316	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Award of stock

	John M. Mount, Jr.	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did CHE director John Meredith Mount Jr. report?

He reported a grant of 386 shares of CHEMED CORP capital stock. The Form 4 identifies this as a non-derivative grant or award acquisition, classified under transaction code A and supported by a footnote stating it is an award of stock.

Was the CHE Form 4 transaction a market buy or a stock award?

The transaction was a stock award, not a market purchase. It is coded A for grant, award, or other acquisition, and the footnote explicitly describes it as an award of stock granted to the reporting director as compensation.

How many CHEMED CORP shares does the director hold after this award?

After receiving the 386-share award, the director holds 1,316 shares. This total reflects his direct ownership of Chemed capital stock immediately following the reported non-derivative grant on May 18, 2026, as disclosed in the filing data.

Does the CHE Form 4 show any stock sales or disposals by the director?

The Form 4 shows no sales or disposals. It lists a single non-derivative acquisition coded A for a grant or award, with zero reported sell, gift, tax-withholding, or restructuring transactions in the transaction summary section.